(2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-[4-chloro-3-(4-ethoxybenzyl)phenyl]tetrahydro-2H-pyran-3,4,5-triyl triacetatee (CAS 461432-25-2-7)

Chemox Pharma is a trusted global supplier and manufacturer of (2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-[4-chloro-3-(4-ethoxybenzyl)phenyl]tetrahydro-2H-pyran-3,4,5-triyl triacetate (CAS No.: 461432-25-2-7), a critical intermediate in the synthesis of Dapagliflozin, an SGLT2 inhibitor widely used in the treatment of type 2 diabetes mellitus.

As an ISO 9001:2015 certified company, Chemox Pharma specializes in providing high-quality APIs and intermediates for both research purposes and large-scale commercial production. Every batch is manufactured with strict adherence to global regulatory requirements (DCGI, WHO-GMP, FDA), ensuring consistency, purity, and compliance.

Chemox Pharma is committed to quality assurance, transparency, and regulatory excellence, making us a trusted partner for global pharmaceutical industries. With a well-equipped R&D centre, we continuously focus on process optimization, cost efficiency, and quality improvements.